Healixa Inc., a Multifaceted Company Merging Healthtech and

New Post Public Reply Private Reply Replies (1) Message Board
Mauibound
400
Healixa Inc., a Multifaceted Company Merging Healthtech and Fintech, is Featured on The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - March 8, 2021) - The Stock Day Podcast welcomed Healixa Inc., formerly Emerald Organic Products Inc., (OTC Pink: EMOR) ("the Company" , a technology company with assets in both healthtech and fintech. CEO of the Company, Ian Parker, joined Stock Day host Everett Jolly.

Jolly began the interview by asking about the Company's recent name change from Emerald Organic Products Inc. to Healixa Inc. "What we're going to be discussing today is our financial technology assets and how they fit hand-in-glove with the healthtech assets that we have," explained Parker. "The name 'Healixa' is reflective of all of those healing technologies, healthtech and fintech, that are essential to our very diverse customer base," he continued. "That's why we changed the name to 'Healixa', so that we could speak to all of the healing technologies that we have and not just a segment of them."

"How are you going to start merging healthtech and fintech?" asked Jolly. "By integrating our proprietary eWallet into our care environment, we can help simplify getting social assistance to those who need it most," explained Parker, before elaborating on the eWallet and social services process. Parker then discussed the traditional social services process, which typically takes 6-8 weeks to complete. "With the program that we have, we now cut that timeframe down to 1-3 days," said Parker. "What we want to provide is a complete continuum of care to help you find all of your critical needs right inside of our care ecosystem."

"What we want to limit is the amount of times that we have to refer you to a third party or have you leave the ecosystem to find that next chain of care," continued Parker, adding that patients within the network can receive treatment for physical and mental health conditions, while also having access to social services.

Jolly then asked about the future of virtual health care. "This is a paradigm shift," said Parker. "You've now moved healthcare into the digital age, you've moved it into the on-demand economy," continued Parker. "The pandemic has forced healthcare to be a rapid adoption of technology, so what you're seeing is a rapid digitization of healthcare," he said. "The next pieces for us are to continue building onto what we already have in terms of digitization."

"What does the roadmap for Healixa look like going forward over the next two to four quarters?" asked Jolly. "This quarter, we are actually starting to produce revenue. Next quarter, we will be continuing to build on those revenues. We have gone to market in this particular quarter," shared Parker. "We have a pipeline of transactions on the pharmacy side that will quickly ramp up our revenues," he continued. "From a technology standpoint, we are beyond a minimum viable product; we are far more advanced than that."

To close the interview, Parker elaborated on the Company's commitment to providing a healing environment for patients across the United States. "We look forward to having people join that ecosystem so that we can help get people the care that they need," said Parker. He then shared that the Company is continuing to grow their experience and knowledge by adding to their diverse panel of experts as they continue to move forward in this space.

To hear Ian Parker's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7817665-healixa-inc-a-multifaceted-company-merging-healthtech-and-fintech-is-featured-on-the-stock-day

Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/

About Emerald Organic Products

Emerald Organic Products Inc. has recently changed its name to Healixa Inc. in the State of Nevada and continues to trade under the symbol OTC Pink: EMOR. Filings have been made to reflect the name change on the OTC ticker board.

About Healixa Inc.

Healixa is a technology company with assets in both healthtech and fintech. Healixa marries code and care to create exceptional experiences in healthtech. The Company's people-first approach is designed to humanize care via purpose-driven ethical engineering practices, deploying simple solutions for complex global challenges.

Healixa offers value-based tech solutions to enterprise partner channels across a broad range of industries including employer benefits, travel, pharma, logistics and more

https://investorshangout.com/recentnews/EMOR#ixzz6oeXs3xvX

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 421

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 281

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 282

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 34

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 536

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 462

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 547

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 308

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 243

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

H.I.G. Realty Forms Innovative Partnership to Foster Growth

Updated Category News Views 271

H.I.G. Realty Collaborates with Queen Mary BioEnterprises H.I.G. Capital, a prominent global alternative investment firm with an impressive $67 billion in capital under management, has exciting news to share. They have entered a strategic partnership with Queen Mary BioEnterprises Innovation Centre, located in the bustling area of Whitechapel, London. This collaboration...

Continue Reading
Hycroft Mines Q2 Shows Stability and Expansion Plans

Updated Category News Views 28

Riding High with a Safety Record and Cash Reserves Hycroft Mining Holding Corporation isn't just treading water—they're swimming strong, closing out Q2 of 2026 with zero injuries and a whopping $220.5 million in the bank. No debt, zero accidents, and 1.4 million work hours without an incident—those are numbers you don't just stumble upon. This is a sign of a company...

Continue Reading
Exciting Collaboration Between Financial Associations for 2026

Updated Category News Views 235

Exciting Collaboration Between Financial Associations for 2026 Financial Executives International (FEI) and the Media Financial Management Association (MFM) have made a significant announcement about their 2026 Annual Conference. This event is set to be a landmark occasion as they will co-locate and co-brand the conference, bringing in financial leaders from across...

Continue Reading
Breakthrough in Gene-Editing Therapy Revolutionizes Hyperlipidemia Treatment

Updated Category News Views 279

Revolutionary Gene-Editing Therapy for Hyperlipidemia Unveiled CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy In a groundbreaking announcement, CorrectSequence Therapeutics Co., Ltd. has reported a notable milestone in the medical field. The completion of dosing for the first...

Continue Reading
Socket Mobile's CaptureSDK 2.0 Revolutionizes Data Capture Solutions

Updated Category News Views 124

Socket Mobile Launches CaptureSDK 2.0 for Enhanced Data Capture Socket Mobile, Inc. (NASDAQ: SCKT), a prominent player in the data capture industry, has made a significant leap forward with the introduction of CaptureSDK 2.0. This robust software solution sets the stage for a new generation of efficient and cost-effective barcode scanners that promise to benefit both...

Continue Reading